We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
Hologic to buy molecular diagnostics firm Biotheranostics for $230m
Biotheranostics is engaged in the development and distribution of diagnostic, prognostic and predictive tests. (Credit: Adam Radosavljevic from Pixabay)